Biotechnology & Life Sciences Global On demand · 24-48h

Global Veterinary Continuous Glucose Monitoring (CGM) Devices Market Strategic Research Report

Global Veterinary Continuous Glucose Monitoring (CGM) Device…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Continuous Glucose Monitoring (CGM) Devices Market
$78.4B2025
12.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Flash Glucose Sensors, Real-Time CGM Sensors, Canine Diabetes Mgmt

By Application: Feline Diabetes Mgmt, Equine Monitoring, Veterinary Critical Care

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Market size 2025
$78.4B
Billion USD
Forecast CAGR
12.3%
2025-2032
Forecast 2032
$176.6B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

The global veterinary continuous glucose monitoring (CGM) devices market represents a specialized but rapidly expanding segment within veterinary diagnostics, valued at approximately USD 78.4 million in 2024. The market sits at the intersection of two powerful forces: the rising prevalence of diabetes mellitus in companion animals and the accelerating adoption of human-grade medical technology adapted for veterinary use. Diabetic dogs and cats collectively account for an estimated 1 in 300 to 1 in 500 veterinary clinical presentations in developed markets, creating sustained demand for real-time glycemic tracking tools that outperform the discomfort and data sparsity of traditional spot-check glucometry. As pet humanization deepens across North America, Western Europe, and select Asia Pacific markets, pet owners increasingly demand the same standard of chronic disease management for their animals that they expect for themselves, giving CGM devices a structurally expanding addressable market.

Market snapshot

Global Veterinary Continuous Glucose Monitoring (CGM) Devices Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$78.4B
2025
Forecast
$176.6B
2032
Volume
1.2
Million Units, 2025
Volume 2032
2.7
Million Units
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Flash Glucose SensorsReal-Time CGM SensorsCanine Diabetes Mgmt
By Application
Feline Diabetes MgmtEquine MonitoringVeterinary Critical Care

Table of contents

Click a chapter to expand
01Executive Summary
  • 1.1 Market Synopsis
  • 1.2 Key Findings
  • 1.3 Strategic Recommendations
02Industry Overview & Forecast
  • 2.1 Market Definition & Scope
  • 2.2 Market Value & Volume Forecast, 2025-2032 (Million Units)
  • 2.3 CAGR Analysis & Confidence Intervals
  • 2.4 Historical Market Review, 2019-2024
  • 2.5 Scenario Analysis (Base, Bull, Bear Cases)
03Market Segmentation by Type
  • 3.1 Market by Device Type Overview
  • 3.2 Flash Glucose Monitoring (FGM) Sensors — Veterinary-Adapted (Value & Volume)
  • 3.3 Real-Time Continuous Glucose Monitoring (rtCGM) Sensors (Value & Volume)
  • 3.4 Implantable Subcutaneous CGM Sensors for Animals (Value & Volume)
  • 3.5 CGM Receiver & Data Transmitter Hardware (Value & Volume)
  • 3.6 Integrated CGM Software & Cloud Analytics Platforms (Value)
04Market Segmentation by Application
  • 4.1 Market by Application Overview
  • 4.2 Canine Diabetes Management (Value & Volume)
  • 4.3 Feline Diabetes Management (Value & Volume)
  • 4.4 Equine Metabolic Syndrome & Insulin Dysregulation Monitoring (Value & Volume)
  • 4.5 Perioperative & Critical Care Glycemic Monitoring in Veterinary ICUs (Value & Volume)
  • 4.6 Veterinary Research & Preclinical Animal Studies (Value)
05Regional Market Forecast
  • 5.1 Regional Revenue Share & CAGR (2024 vs 2032)
  • 5.2 North America (Value & Volume)
  • 5.3 Europe (Value & Volume)
  • 5.4 Asia Pacific (Value & Volume)
  • 5.5 Latin America
  • 5.6 Middle East & Africa
06Country-Level Market Forecast
  • 6.1 Top Countries Overview
  • 6.2 United States
  • 6.3 United Kingdom
  • 6.4 Germany
  • 6.5 Australia
  • 6.6 Canada
  • 6.7 Japan
07Growth Drivers & Inhibitors
  • 7.1 Rising Prevalence of Diabetes Mellitus and Obesity in Companion Animals
  • 7.2 Off-Label Adoption of Human Flash Glucose Sensors (Abbott Libre, Dexcom G-Series) Accelerating Clinical Familiarity
  • 7.3 Expansion of Veterinary Telehealth Platforms Enabling Remote CGM Data Interpretation
  • 7.4 Market Restraints & Challenges
  • 7.5 Opportunities & White-Space Analysis
08Key Company Profiles
  • 8.1 Abbott Laboratories — Revenue, Strategy, FreeStyle Libre (Off-Label Veterinary Use)
  • 8.2 Dexcom, Inc. — Revenue, Strategy, G6 & G7 Sensor Adaptation in Veterinary Settings
  • 8.3 Medtronic plc — Revenue, Strategy, Guardian CGM Systems in Animal Health Research
  • 8.4 Zoetis Inc. — Revenue, Strategy, Animal Health Diagnostics & Digital Monitoring
  • 8.5 IDEXX Laboratories, Inc. — Revenue, Strategy, Point-of-Care Glucose Diagnostics
  • 8.6 Agamatrix, Inc. — Revenue, Strategy, Veterinary-Specific WaveSense Glucometry
  • 8.7 i-SENS, Inc. — Revenue, Strategy, CareSens Glucose Monitoring for Veterinary Markets
  • 8.8 Heska Corporation — Revenue, Strategy, In-House Veterinary Diagnostics Portfolio
  • 8.9 Digicare Biomedical Technology — Revenue, Strategy, Continuous Veterinary Patient Monitoring
  • 8.10 GlySens Incorporated — Revenue, Strategy, Long-Term Implantable Glucose Sensor Development
09Competitive Landscape
  • 9.1 Market Concentration & Competitive Intensity
  • 9.2 Market Share Analysis (2024)
  • 9.3 Competitive Positioning Matrix
  • 9.4 Recent Developments: M&A, Partnerships & Product Launches (2023-2025)
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitute Products
  • 10.5 Competitive Rivalry Intensity
11PESTLE Analysis
  • 11.1 Political Factors
  • 11.2 Economic Factors
  • 11.3 Social & Demographic Factors
  • 11.4 Technological Factors
  • 11.5 Legal & Regulatory Factors
  • 11.6 Environmental Factors
12SWOT Analysis
  • 12.1 Market-Level Strengths
  • 12.2 Market-Level Weaknesses
  • 12.3 Strategic Opportunities
  • 12.4 External Threats
13Future Trends & Outlook
  • 13.1 Development of Species-Specific Veterinary-Approved CGM Sensors with USDA/EMA Regulatory Clearance
  • 13.2 Integration of CGM Data Streams with AI-Powered Insulin Dosing Decision Support for Veterinarians
  • 13.3 Emergence of Multianalyte Wearable Patches Combining Glucose, Ketone, and Cortisol Sensing in Animals
  • 13.4 Long-Term Market Outlook (2033-2035)
  • 13.5 Investment & M&A Activity Outlook

Frequently asked questions

What is the size of the veterinary CGM devices market?
The global veterinary continuous glucose monitoring devices market was valued at approximately USD 78.4 million in 2024 and is projected to reach USD 198.6 million by 2032, driven by rising companion animal diabetes prevalence and expanding telehealth adoption in veterinary practice. In volume terms, the market is estimated at approximately 1.2 million sensor units deployed in 2024.
What is the CAGR of the veterinary CGM devices market?
The global veterinary CGM devices market is projected to grow at a compound annual growth rate of approximately 12.3% over the forecast period from 2025 to 2032, reflecting strong underlying demand from companion animal diabetic populations and accelerating technology adoption across North American and European veterinary practices.
What is driving growth in the veterinary CGM devices market?
The three primary growth drivers are: (1) the documented increase in diabetes mellitus and obesity in companion animals, particularly dogs and cats, which directly expands the patient population requiring continuous glycemic monitoring; (2) the established off-label use of human-grade flash glucose sensors such as Abbott's FreeStyle Libre in veterinary clinical settings, which has accelerated clinician familiarity and reduced technology adoption barriers; and (3) the proliferation of veterinary telehealth platforms that enable remote CGM data interpretation, making continuous monitoring practically viable in home-care settings and extending the market beyond specialist hospitals.
Who are the leading companies in the veterinary CGM devices market?
The market is currently shaped by human CGM manufacturers whose devices are adopted off-label in veterinary settings, alongside dedicated animal health diagnostics companies. Key players include Abbott Laboratories (FreeStyle Libre), Dexcom (G6/G7 sensors), Zoetis Inc., IDEXX Laboratories, and Heska Corporation. Purpose-built veterinary CGM development activity is emerging from companies including Agamatrix and GlySens Incorporated.
Which region dominates the veterinary CGM devices market?
North America is the dominant regional market, accounting for an estimated 46% of global revenue in 2024. The United States drives the majority of this share, underpinned by the world's largest companion animal population, high per-capita veterinary spending, widespread pet insurance coverage, and a dense network of specialist and emergency veterinary hospitals with existing point-of-care diagnostics infrastructure.
What segments are covered in this report?
The report covers segmentation by device type — including flash glucose monitoring sensors, real-time CGM sensors, implantable subcutaneous sensors, CGM receiver and transmitter hardware, and integrated software platforms — and by application, including canine diabetes management, feline diabetes management, equine metabolic syndrome monitoring, perioperative and critical care glycemic monitoring, and veterinary research use. Regional coverage spans North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, with country-level detail for the United States, United Kingdom, Germany, Australia, Canada, and Japan.
What is the forecast period covered in this report?
This report covers the forecast period from 2025 to 2032, with 2024 as the base year. Historical market data is provided for the 2019–2024 period to contextualize growth trajectories and the impact of COVID-19 pandemic-era disruptions on veterinary service utilization and device procurement.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.